{
    "score": [
        1.0
    ],
    "extracted": [
        0
    ],
    "abstract": [
        "tandem diabetes care downgraded by zacks investment research ."
    ],
    "id": "1137041.train",
    "article": [
        "tandem diabetes care was downgraded by zacks investment research from a `` buy '' rating to a `` hold '' rating in a note issued to investors on saturday . according to zacks , `` tandem diabetes care , inc. . is a medical device company . the company designs , develops , and commercializes products for people with insulin-dependent diabetes . its products include t : slim insulin delivery system . tandem diabetes care , inc. . is headquartered in san diego , california . `` tndm has been the topic of several other research reports . wedbush reissued an `` outperform '' rating and set a $ 17.00 target price on shares of tandem diabetes care in a research report on tuesday , october 10th . ",
        "piper jaffray companies reissued a `` hold '' rating and set a $ 15.00 target price on shares of tandem diabetes care in a research report on friday , october 6th . finally , robert w. baird reissued a `` hold '' rating and set a $ 3.00 target price on shares of tandem diabetes care in a research report on sunday , november 19th . five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock . the stock presently has a consensus rating of `` hold '' and a consensus target price of $ 11.29 . ",
        "shares of tandem diabetes care traded up $ 0.03 during trading on friday , hitting $ 2.91 . 826,706 shares of the stock were exchanged , compared to its average volume of 779,387 . the company has a debt-to-equity ratio of -2.70 , a quick ratio of 0.88 and a current ratio of 1.90 . tandem diabetes care has a 52-week low of $ 2.15 and a 52-week high of $ 30.00 . the stock has a market cap of $ 29.14 , a p/e ratio of -0.15 and a beta of 0.17 . tandem diabetes care last released its earnings results on thursday , october 26th . ",
        "the medical device company reported earnings per share for the quarter , topping the consensus estimate of by $ 0.65 . the company had revenue of $ 27.00 million for the quarter , compared to analysts ' expectations of $ 25.92 million . the firm 's revenue for the quarter was up 119.7 % on a year-over-year basis . during the same period in the prior year , the firm posted eps . equities research analysts expect that tandem diabetes care will post -15.37 earnings per share for the current fiscal year . a number of large investors have recently added to or reduced their stakes in tndm . ",
        "wedbush securities inc. . grew its position in tandem diabetes care by 88.6 % during the 3rd quarter . wedbush securities inc. . now owns 188,877 shares of the medical device company 's stock worth $ 138,000 after purchasing an additional 88,709 shares during the last quarter . russell investments group ltd. . boosted its holdings in shares of tandem diabetes care by 13.5 % in the 3rd quarter . russell investments group ltd. . now owns 659,993 shares of the medical device company 's stock valued at $ 482,000 after acquiring an additional 78,748 shares during the last quarter . ",
        "finally , vanguard group inc. . boosted its holdings in shares of tandem diabetes care by 2.7 % in the 2nd quarter . vanguard group inc. . now owns 1,233,607 shares of the medical device company 's stock valued at $ 987,000 after acquiring an additional 32,991 shares during the last quarter . copyright violation warning : this story was originally reported by american banking news and is owned by of american banking news . if you are viewing this story on another site , it was illegally copied and republished in violation of u. s. and international copyright & trademark legislation . ",
        "the correct version of this story can be viewed at diabetes care company profiletandem diabetes care , inc is a medical device company . the company is engaged in designing , developing and commercializing products for people with insulin-dependent diabetes . the company manufactures and sells three insulin pump products , which include t : slim insulin delivery system , t : flex insulin delivery system and t : slim g4 insulin delivery system . get a free copy of the zacks research report on tandem diabetes care for more information about research offerings from zacks investment research , visit zacks . ",
        "comreceive news & ratings for tandem diabetes care daily - enter your email address below to receive a concise daily summary of the latest news and analysts ' ratings for tandem diabetes care and related companies with marketbeat . com 's free daily email newsletter .   "
    ]
}